Skip to main content
Terug
Watch Compare

Health Catalyst, Inc.

Datakwaliteit: 100%
HCAT
Nasdaq Technology IT Services
€ 1,00
▼ € 0,01 (-1,39%)
Marktkapitalisatie: 73,95 M
Prijs
€ 1,01
Marktkapitalisatie
73,95 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 6,49% annually over 5 years — modest growth
Debt/Equity of 0,46 — conservative balance sheet
Negative free cash flow of -237.000,0
Revenue growth is decelerating — 1Y growth trails 5Y average by 5,01%
Capital efficient — spends only 0,31% of revenue on capex

Groei

Revenue Growth (5Y)
6,49%
Onder sectorgemiddelde (7,29%)
Revenue (1Y)1,48%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-52,39%
Onder sectorgemiddelde (1,78%)
ROIC-25,00%
Net Margin-57,20%
Op. Margin-51,70%

Veiligheid

Debt / Equity
0,46
Boven sectorgemiddelde (0,42)
Current Ratio1,88
Interest CoverageN/A

Waardering

PE (TTM)
-0,42
Onder sectorgemiddelde (-0,15)
P/B Ratio0,22
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Technology sector mediaan (1058 peers)
Metriek Aandeel Sector Mediaan
P/E -0,4 -0,2
P/B 0,2 3,0
ROE % -52,4 1,8
Net Margin % -57,2 -0,5
Rev Growth 5Y % 6,5 7,3
D/E 0,5 0,4

ETFs Holding This Stock

ASCZX ASCZX
0,31% weight
AGSCX AGSCX
0,31% weight
ALSCX ALSCX
0,31% weight
ASCYX ASCYX
0,31% weight
ALSAX ALSAX
0,31% weight
ASIRX ASIRX
0,26% weight
ALSRX ALSRX
0,26% weight
AISZX AISZX
0,26% weight
BOGIX BOGIX
0,10% weight
IJSTX IJSTX
0,05% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 1,48% Revenue Growth (3Y) 2,54%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 6,49% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 311,14 M Net Income (TTM) -177,97 M
ROE -52,39% ROA -29,58%
Gross Margin N/A Operating Margin -51,70%
Net Margin -57,20% Free Cash Flow (TTM) -237.000,0
ROIC -25,00% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,46 Current Ratio 1,88
Interest Coverage N/A Asset Turnover 0,52
Working Capital 77,46 M Tangible Book Value -43,22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,42 Forward P/E N/A
P/B Ratio 0,22 P/S Ratio 0,24
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,32%
Market Cap 73,95 M Enterprise Value 186,79 M
Per Share
EPS (Diluted TTM) -2,55 Revenue / Share 4,23
FCF / Share 0,00 OCF / Share 0,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,31% FCF Conversion 0,13%
SBC-Adj. FCF -32,65 M Growth Momentum -5,01

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 311,14 M 306,58 M 295,94 M 276,24 M 241,93 M
Net Income -177,97 M -69,50 M -118,15 M -137,40 M -153,21 M
EPS (Diluted) -2,55 -1,15 -2,09 -2,63 -3,23
Gross Profit — — — — —
Operating Income -160,85 M -69,81 M -126,90 M -140,01 M -143,65 M
EBITDA — — — — —
R&D Expenses 49,77 M 57,95 M 72,63 M 75,68 M 62,73 M
SG&A Expenses — — — — —
D&A 50,50 M 41,43 M 42,22 M 48,30 M 37,53 M
Interest Expense — — — — —
Income Tax 716.000,0 333.000,0 356.000,0 -4,28 M -6,90 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 502,64 M 858,93 M 701,81 M 752,29 M 832,10 M
Total Liabilities 256,86 M 493,72 M 334,90 M 327,28 M 310,00 M
Shareholders' Equity 245,78 M 365,21 M 366,92 M 425,01 M 522,10 M
Total Debt 153,25 M 382,36 M 228,03 M 226,52 M 180,94 M
Cash & Equivalents 50,81 M 249,65 M 106,28 M 116,31 M 193,23 M
Current Assets 169,31 M 465,65 M 393,40 M 427,80 M 508,39 M
Current Liabilities 89,57 M 325,85 M 89,03 M 82,51 M 93,05 M